These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 32979569)

  • 1. Understanding the role of bacterial and fungal infection in COVID-19.
    Rawson TM; Wilson RC; Holmes A
    Clin Microbiol Infect; 2021 Jan; 27(1):9-11. PubMed ID: 32979569
    [No Abstract]   [Full Text] [Related]  

  • 2. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.
    Rawson TM; Moore LSP; Zhu N; Ranganathan N; Skolimowska K; Gilchrist M; Satta G; Cooke G; Holmes A
    Clin Infect Dis; 2020 Dec; 71(9):2459-2468. PubMed ID: 32358954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fungal superinfection in patients with COVID-19: Role of antifungal stewardship?
    Nestler M; Godbout E; Lee K; Kim J; Noda AJ; Taylor P; Pryor R; Markley JD; Doll M; Bearman G; Stevens MP
    Am J Infect Control; 2021 Feb; 49(2):279-280. PubMed ID: 33220338
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study.
    Garcia-Vidal C; Sanjuan G; Moreno-García E; Puerta-Alcalde P; Garcia-Pouton N; Chumbita M; Fernandez-Pittol M; Pitart C; Inciarte A; Bodro M; Morata L; Ambrosioni J; Grafia I; Meira F; Macaya I; Cardozo C; Casals C; Tellez A; Castro P; Marco F; García F; Mensa J; Martínez JA; Soriano A;
    Clin Microbiol Infect; 2021 Jan; 27(1):83-88. PubMed ID: 32745596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suboptimal antimicrobial stewardship in the COVID-19 era: is humanity staring at a postantibiotic future?
    Owoicho O; Tapela K; Djomkam Zune AL; Nghochuzie NN; Isawumi A; Mosi L
    Future Microbiol; 2021 Aug; 16():919-925. PubMed ID: 34319168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals.
    Seaton RA; Gibbons CL; Cooper L; Malcolm W; McKinney R; Dundas S; Griffith D; Jeffreys D; Hamilton K; Choo-Kang B; Brittain S; Guthrie D; Sneddon J
    J Infect; 2020 Dec; 81(6):952-960. PubMed ID: 32987097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased antimicrobial resistance during the COVID-19 pandemic.
    Lai CC; Chen SY; Ko WC; Hsueh PR
    Int J Antimicrob Agents; 2021 Apr; 57(4):106324. PubMed ID: 33746045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship.
    Rothe K; Feihl S; Schneider J; Wallnöfer F; Wurst M; Lukas M; Treiber M; Lahmer T; Heim M; Dommasch M; Waschulzik B; Zink A; Querbach C; Busch DH; Schmid RM; Schneider G; Spinner CD
    Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):859-869. PubMed ID: 33140176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of superinfection, antimicrobial usage, and airway microbiome with metagenomic sequencing in COVID-19 patients: A cohort study in Shanghai.
    Miao Q; Ma Y; Ling Y; Jin W; Su Y; Wang Q; Pan J; Zhang Y; Chen H; Yuan J; Wu H; Hu B
    J Microbiol Immunol Infect; 2021 Oct; 54(5):808-815. PubMed ID: 34103263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial coinfections in COVID-19: an underestimated adversary.
    Fattorini L; Creti R; Palma C; Pantosti A; ;
    Ann Ist Super Sanita; 2020; 56(3):359-364. PubMed ID: 32959802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial and fungal growth in sputum cultures from 165 COVID-19 pneumonia patients requiring intubation: evidence for antimicrobial resistance development and analysis of risk factors.
    Liu HH; Yaron D; Piraino AS; Kapelusznik L
    Ann Clin Microbiol Antimicrob; 2021 Sep; 20(1):69. PubMed ID: 34563202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Could the COVID-19 pandemic aggravate antimicrobial resistance?
    Rossato L; Negrão FJ; Simionatto S
    Am J Infect Control; 2020 Sep; 48(9):1129-1130. PubMed ID: 32603851
    [No Abstract]   [Full Text] [Related]  

  • 13. When two for the price of one isn't a bargain: estimating prevalence and microbiology of bacterial co-infections in patients with COVID-19.
    Thaden JT; Maskarinec SA
    Clin Microbiol Infect; 2020 Dec; 26(12):1602-1603. PubMed ID: 32919069
    [No Abstract]   [Full Text] [Related]  

  • 14. The microbial coinfection in COVID-19.
    Chen X; Liao B; Cheng L; Peng X; Xu X; Li Y; Hu T; Li J; Zhou X; Ren B
    Appl Microbiol Biotechnol; 2020 Sep; 104(18):7777-7785. PubMed ID: 32780290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superinfection with difficult-to-treat bacteria in COVID-19 patients: a call for compliance with diagnostic and antimicrobial stewardship.
    Para O; Caruso L; Ronchetti M; Finocchi M; Guidi S; Spinicci M
    Intern Emerg Med; 2021 Apr; 16(3):789-791. PubMed ID: 33222117
    [No Abstract]   [Full Text] [Related]  

  • 16. Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.
    Hughes S; Troise O; Donaldson H; Mughal N; Moore LSP
    Clin Microbiol Infect; 2020 Oct; 26(10):1395-1399. PubMed ID: 32603803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibiotics and antimicrobial resistance in the COVID-19 era: Perspective from resource-limited settings.
    Lucien MAB; Canarie MF; Kilgore PE; Jean-Denis G; Fénélon N; Pierre M; Cerpa M; Joseph GA; Maki G; Zervos MJ; Dely P; Boncy J; Sati H; Rio AD; Ramon-Pardo P
    Int J Infect Dis; 2021 Mar; 104():250-254. PubMed ID: 33434666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia.
    Chong WH; Saha BK; Ananthakrishnan Ramani ; Chopra A
    Infection; 2021 Aug; 49(4):591-605. PubMed ID: 33709380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Physiopathology and therapy in patients with respiratory tract infections].
    Saito A
    Nihon Naika Gakkai Zasshi; 1993 Mar; 82(3):433-6. PubMed ID: 8315342
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: A systematic review and meta-analysis.
    Musuuza JS; Watson L; Parmasad V; Putman-Buehler N; Christensen L; Safdar N
    PLoS One; 2021; 16(5):e0251170. PubMed ID: 33956882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.